Funder: Centers for Disease Control and Prevention - ERA
Due Dates: November 6, 2026 (Optional letter of intent) | December 8, 2026 (Application) | September 24, 2027 (Optional letter of intent) | October 26, 2027 (Application)
Funding Amounts: Up to $365,000 annually and $500,000 total over two years; $18 million estimated program funding
Summary: Supports early-stage exploratory research to improve diagnosis, treatment, care, and well-being for people exposed to the September 11 attacks.
Key Information: Foreign institutions, non-U.S. components of U.S. organizations, and foreign components are ineligible.
Description
The World Trade Center (WTC) Health Program, administered by CDC’s National Institute for Occupational Safety and Health (NIOSH), supports exploratory and developmental R21 research addressing diagnostic or treatment uncertainty among populations exposed to the September 11, 2001, terrorist attacks. Projects should test the feasibility of new approaches, interventions, techniques, or methods, with minimal or no preliminary data expected.
Research should improve WTC Health Program diagnosis and treatment, expand knowledge of 9/11-related health effects, answer physical or mental health questions, or apply lessons to future disaster responses. The program encourages evidence-based diagnostic, treatment, and program-evaluation strategies, lifestyle medicine research, and studies focused solely on survivors. Projects are expected to break new ground or extend prior discoveries, with findings that can translate into better member care.
